Acarix A/S Asset Resilience Ratio
Acarix A/S asset resilience ratio. Acarix A/S (ACARIX) has an Asset Resilience Ratio of 37.81% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ACARIX days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Acarix A/S (2015–2024)
Asset resilience ratio of Acarix A/S from 2015 to 2024. This chart shows how Acarix A/S's Asset Resilience Ratio has changed over time. Read debt load of Acarix A/S for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Acarix A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Acarix A/S assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr18.27 Million | 37.81% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr18.27 Million | 37.81% |
Asset Resilience Insights
- Very High Liquidity: Acarix A/S maintains exceptional liquid asset reserves at 37.81% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Acarix A/S Industry Peers by Asset Resilience Ratio
Compare Acarix A/S's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Acarix A/S Asset Resilience Ratio by Year (2015–2024)
Acarix A/S asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for Acarix A/S.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.19% | Skr152.00K ≈ $16.36K |
Skr80.76 Million ≈ $8.69 Million |
-0.05pp |
| 2023-12-31 | 0.23% | Skr147.00K ≈ $15.82K |
Skr62.88 Million ≈ $6.77 Million |
-16.04pp |
| 2022-12-31 | 16.28% | Skr11.31 Million ≈ $1.22 Million |
Skr69.48 Million ≈ $7.48 Million |
+2.79pp |
| 2021-12-31 | 13.49% | Skr16.00 Million ≈ $1.72 Million |
Skr118.60 Million ≈ $12.76 Million |
+13.27pp |
| 2020-12-31 | 0.22% | Skr195.00K ≈ $20.99K |
Skr89.95 Million ≈ $9.68 Million |
-0.07pp |
| 2019-12-31 | 0.28% | Skr234.00K ≈ $25.18K |
Skr82.98 Million ≈ $8.93 Million |
-68.19pp |
| 2018-12-31 | 68.48% | Skr65.19 Million ≈ $7.02 Million |
Skr95.20 Million ≈ $10.24 Million |
-8.79pp |
| 2017-12-31 | 77.27% | Skr103.58 Million ≈ $11.15 Million |
Skr134.06 Million ≈ $14.43 Million |
-6.97pp |
| 2016-12-31 | 84.24% | Skr145.97 Million ≈ $15.71 Million |
Skr173.29 Million ≈ $18.65 Million |
+83.89pp |
| 2015-12-31 | 0.35% | Skr54.00K ≈ $5.81K |
Skr15.58 Million ≈ $1.68 Million |
-- |
About Acarix A/S
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Au… Read more